NDC 17856-0125

Phenohytro

Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, And Scopolamine Hydrobromide

Phenohytro is a Oral Elixir in the Human Prescription Drug category. It is labeled and distributed by Atlantic Biologicals Corp.. The primary component is Phenobarbital; Hyoscyamine Sulfate; Atropine Sulfate; Scopolamine Hydrobromide.

Product ID17856-0125_1866665a-4045-4842-a9f3-d32e3485a27f
NDC17856-0125
Product TypeHuman Prescription Drug
Proprietary NamePhenohytro
Generic NamePhenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, And Scopolamine Hydrobromide
Dosage FormElixir
Route of AdministrationORAL
Marketing Start Date2018-08-30
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameATLANTIC BIOLOGICALS CORP.
Substance NamePHENOBARBITAL; HYOSCYAMINE SULFATE; ATROPINE SULFATE; SCOPOLAMINE HYDROBROMIDE
Active Ingredient Strength16 mg/5mL; mg/5mL; mg/5mL; mg/5mL
Pharm ClassesAnticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 17856-0125-1

72 CUP, UNIT-DOSE in 1 BOX (17856-0125-1) > 10 mL in 1 CUP, UNIT-DOSE
Marketing Start Date2020-05-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 17856-0125-1 [17856012501]

Phenohytro ELIXIR
Marketing CategoryUNAPPROVED DRUG OTHER
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-05-20
Inactivation Date2020-01-31
Reactivation Date2020-05-20

NDC 17856-0125-2 [17856012502]

Phenohytro ELIXIR
Marketing CategoryUNAPPROVED DRUG OTHER
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-05-20
Inactivation Date2020-01-31
Reactivation Date2020-05-20

Drug Details

Active Ingredients

IngredientStrength
PHENOBARBITAL16.2 mg/5mL

OpenFDA Data

SPL SET ID:a5aaf1db-1938-4073-9da4-c47f959d013e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2048017
  • 1046787
  • Pharmacological Class

    • Anticholinergic [EPC]
    • Cholinergic Antagonists [MoA]
    • Cholinergic Muscarinic Antagonist [EPC]
    • Cholinergic Muscarinic Antagonists [MoA]
    • Anticholinergic [EPC]
    • Cholinergic Antagonists [MoA]

    NDC Crossover Matching brand name "Phenohytro" or generic name "Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, And Scopolamine Hydrobromide"

    NDCBrand NameGeneric Name
    17856-0123PhenohytroPhenobarbital, Hyoscyamine Sulfate, Atropine sulfate, and Scopolamine Hydrobromide
    17856-0125PhenohytroPhenobarbital, Hyoscyamine Sulfate, Atropine sulfate, and Scopolamine Hydrobromide
    75826-118PhenohytroPHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE
    75826-127PhenohytroPhenobarbital, Hyoscyamine Sulfate, Atropine sulfate, and Scopolamine Hydrobromide
    75826-128PhenohytroPhenobarbital, Hyoscyamine Sulfate, Atropine sulfate, and Scopolamine Hydrobromide

    Trademark Results [Phenohytro]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    PHENOHYTRO
    PHENOHYTRO
    86924465 5168062 Live/Registered
    Winder Laboratories LLC
    2016-03-01

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.